The finding that unsteadiness was the other most notable discriminatory symptom may be consistent with this: 15% vs 4% (or 19% vs 4% of insulin-treated) patients with/without hypoglycaemia on another occasion presented with unsteadiness. This evidence concerns the gene INS and Hypoglycemia.